89879688987: Difference between revisions
From Verified Handles
An Israeli company engaged in the development of human placental adherent stromal cells for commercial use.
89879688987
89879688987
(Pluristem Therapeutics) |
(AB-V1) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Pluristem Therapeutics}} | {{DISPLAYTITLE:Pluristem Therapeutics}} | ||
Pluristem Therapeutics is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment.<small> from [https://en.wikipedia.org/wiki/Pluristem_Therapeutics Wikipedia]</small> | Pluristem Therapeutics is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.<small> from [https://en.wikipedia.org/wiki/Pluristem_Therapeutics Wikipedia]</small> | ||
{| | {{SF| | ||
{{Twt|pluristem}} | {{Twt|pluristem}} | ||
{{Wb|http://www.pluristem.com/|pluristem.com}} | {{Wb|http://www.pluristem.com/|pluristem.com}} | ||
{{Fb|Pluristem}} | |||
{{Yt|UC65WAbsbyKFNqvWWkfWZkKQ|Pluristem Therapeutics}} | {{Yt|UC65WAbsbyKFNqvWWkfWZkKQ|Pluristem Therapeutics}} | ||
}} | |||
{{VHID|89879688987}}{{#subtitle: <big>An Israeli company engaged in the development of human placental adherent stromal cells for commercial use.</big>}} | |||
{{#subtitle: <big>An Israeli company engaged in the development of human placental adherent stromal cells for commercial use.</big>}} | |||
Latest revision as of 19:30, 27 February 2022
Pluristem Therapeutics is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. from Wikipedia
| Icon | Service | Username | |
|---|---|---|---|
| @pluristem | |||
| Website | pluristem.com | ||
| @Pluristem | |||
| YouTube | @Pluristem Therapeutics |




